跳至主要内容
临床试验/PACTR202105785593643
PACTR202105785593643已完成未知

A Randomised Controlle Study of Vaginal Bromocriptine and Oral Carbegoline in treating Hyperprolacrinemia among women Attending Infertility Clinic in Abuth

Irshad Asma0 个研究点目标入组 60 人开始时间: 2021年4月15日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
Female

入选标准

  • 1.Infertile women with hyperprolactinemia confirmed by measuring fasting serum prolactin levels.
  • 2.Women who give informed consent to participate in the study.
  • 3.Women who are motivated to comply with study requirements including clinic visits, repeated blood sampling, vaginal drug administration and timely use of medication.

排除标准

  • 1.Women with space occupying lesions or other complications requiring urgent intervention.
  • 2.Women with active genital tract infections or cancers.
  • 3.Renal or hepatic insufficiency.
  • 4.Women who were already on treatment at the time of the study.
  • 5.Women who were unable to provide informed consent.
  • 6.Women with allergies to any component of the drugs.

研究者

发起方
Irshad Asma

相似试验